Merck & Co., Inc. Logo

Merck & Co., Inc. (0QAH)

LSE

Currency in USD
151.99
+0.72 (+0.48%)

Real-time Data

07:00 AM

Day's Range

148.60
154.50

52 wk Range

70.15
154.50

Overview - 0QAH - Merck & Co., Inc.

Key Statistics

Valuation

Enterprise Value

292.70B

P/E (Trailing)

‪63.22‬

PEG Ratio

‪-0.48‬

Price / Sales (TTM)

‪3.35‬

Price / Book

‪5.06‬

EV / EBITDA

‪23.74‬

Profitability

Gross Margin

‪73.53%‬

Profit Margin

‪5.33%‬

Operating Margin

‪14.86%‬

Return on Assets

‪5.12%‬

Return on Equity

‪7.61%‬

Ownership

Shares Outstanding

2.46B

Float

2.53B

Held by Insiders

‪0.08%‬

Held by Institutions

‪77.64%‬

Price stats

Beta

‪0.37‬

50-Day Avg

‪127.36‬

200-Day Avg

‪116.14‬

Dividends

Payout Ratio

‪236.07%‬

Frequency

Quarterly

Market Cap - 0QAH - Merck & Co., Inc.

Peers - 0QAH - Merck & Co., Inc.

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on LSE.

Profile Summary - 0QAH - Merck & Co., Inc.

About

Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals such as Keytruda for oncology treatments, Welireg for specific cancer…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees73K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.